GSC The List

Post Reply
Forum Home > M > MULTIPLE SCLEROSIS / MS*+ (2013-2015)

[email protected]
Site Owner
Posts: 1174

Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3625014/

Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis. (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076907

Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062511

Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/

Therapeutic potential of cannabinoid medicines. (full – 2013) http/onlinelibrary.wiley.com/doi/10.1002/dta.1529/full

Multiple sclerosis and the blood-central nervous system barrier. (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3562587/

A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK. (full – 2013) http/onlinelibrary.wiley.com/doi/10.1002/dta.1531/full

Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3648912/

Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors. (full – 2013) http/www.sciencedirect.com/science/article/pii/S0969996113001939

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis. (full – 2013) http/zl.elsevier.es/en/revista/neurologia-495/articulo/clinical-experiences-with-cannabinoids-in-90328787

Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis. (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/

Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23369054

Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23625705

Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23621668

Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23829360

Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/22371074

Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23892791

Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24121462

Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23517929

Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24289844

Still Believe Nature Got It Wrong? Top 10 Health Benefits of Marijuana (news – 2013) http/www.wakingtimes.com/2013/05/01/still-believe-nature-got-it-wrong-top-10-health-benefits-ofmarijuana/

Research shows marijuana can be effectively used to treat multiple sclerosis (news – 2013) http/www.naturalnews.com/042498_marijuana_multiple_sclerosis_natural_treatment.html

Medical Marijuana: Consortium of Multiple Sclerosis Centers (news – 2013) http/www.msviews.org/msviewsandnews4/index.php/2012-05-28-00-15-54/2012-07-04-00-19-28/610-medical-marajuana-consortium-of-multiple-sclerosis-centers

Aylsham multiple sclerosis sufferer says cannabis-based drug ‘changed my life’ (news – 2013) http/www.eveningnews24.co.uk/news/aylsham_multiple_sclerosis_sufferer_says_cannabis_based_drug_changed_my_life_1_2276182

Multiple Sclerosis and Cannabis - A Conversation With Clark French (news – 2013) http/www.huffingtonpost.co.uk/jason-reed/multiple-sclerosis-and-cannabis_b_1902151.html

Sending multiple sclerosis up in smoke (news – 2013) http/www.eurekalert.org/pub_releases/2013-10/afot-sms100713.php

Chemicals in marijuana 'protect nervous system' against MS (news – 2013) http/www.medicalnewstoday.com/articles/267161.php

Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. (full – 2014) http/www.neurology.org/content/82/17/1556.long

Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience. (full – 2014) http/www.karger.com/Article/FullText/357743

THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies. (full – 2014) http/www.karger.com/Article/FullText/357742

Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis (full – 2014) http/www.neurology.org/content/82/12/1083.full

Docosahexaenoyl ethanolamide improves glucose uptake and alters endocannabinoid system gene expression in proliferating and differentiating C2C12 myoblasts. (full – 2014) http/journal.frontiersin.org/Journal/10.3389/fphys.2014.00100/full

The endocannabinoid system: a putative role in neurodegenerative diseases. (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/

Current and future drugs for treatment of MS-associated bladder dysfunction. (full – 2014) http/www.sciencedirect.com/science/article/pii/S187706571401728X

Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosisrelated spasticity. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24392812

Nabiximols (THC/CBD Oromucosal Spray, Sativex® in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24525548

Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®: A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24671907

Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24747979

Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24943098

Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental l-DOPA-induced dyskinesia (abst – 2014) http/onlinelibrary.wiley.com/doi/10.1002/syn.21740/abstract

Study uncovers marijuana's potential to treat autoimmune diseases (news – 2014) http/www.news-medical.net/news/20140603/Study-uncovers-marijuanas-potential-to-treat-autoimmunediseases.aspx

Marijuana Benefits MS Patients as Other Remedies Fail (news – 2014) http/www.bloomberg.com/news/2014-03-24/marijuana-benefits-ms-patients-as-other-remedies-fail.html

Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation (full – 2015) http://www.hindawi.com/journals/np/2015/656582/

Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full – 2015) http://onlinelibrary.wiley.com/doi/10.1002/glia.22742/full

Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/cei.12443/full

Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/pme.12569/full

Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/ane.12287/full

Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726

Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice (abst – 2015) http://www.sciencedirect.com/science/article/pii/S0306452215000858

March 16, 2015 at 11:41 PM Flag Quote & Reply

This topic is closed, no additional posts are allowed.